Related references
Note: Only part of the references are listed.REM Sleep Behavior Disorder (RBD) in Dementia with Lewy Bodies (DLB)
Po-Chi Chan et al.
BEHAVIOURAL NEUROLOGY (2018)
Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated
John L. Robinson et al.
BRAIN (2018)
Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study
Rita Guerreiro et al.
LANCET NEUROLOGY (2018)
Adjunct zonisamide to levodopa for DLB parkinsonism: A randomized double-blind phase 2 study
Miho Murata et al.
NEUROLOGY (2018)
Psychotropic and anti-dementia treatment in elderly persons with clinical signs of dementia with Lewy bodies: a cross-sectional study in 40 nursing homes in Sweden
Iris Zahirovic et al.
BMC GERIATRICS (2018)
Advances in the pharmacotherapeutic management of dementia with Lewy bodies
Giovanni Palermo et al.
EXPERT OPINION ON PHARMACOTHERAPY (2018)
The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease
Diana L. Price et al.
SCIENTIFIC REPORTS (2018)
Valproate for agitation in critically ill patients: A retrospective study
David J. Gagnon et al.
JOURNAL OF CRITICAL CARE (2017)
Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis
David Irwin et al.
LANCET NEUROLOGY (2017)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith et al.
NEUROLOGY (2017)
A new potential biomarker for dementia with Lewy bodies Skin nerve α-synuclein deposits
Vincenzo Donadio et al.
NEUROLOGY (2017)
Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells
Matthias Hoellerhage et al.
SCIENTIFIC REPORTS (2017)
New Therapeutic Strategies for Lewy Body Dementias
Latha Velayudhan et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2017)
Pimavanserin: A novel therapeutic option for Parkinson disease psychosis
Trevor Hawkins et al.
NEUROLOGY-CLINICAL PRACTICE (2017)
Combination therapies: The next logical Step for the treatment of synucleinopathies?
Elvira Valera et al.
MOVEMENT DISORDERS (2016)
Development of Passive Immunotherapies for Synucleinopathies
Ann-Louise Bergstrom et al.
MOVEMENT DISORDERS (2016)
Active immunization therapies for Parkinson's disease and multiple system atrophy
Achim Schneeberger et al.
MOVEMENT DISORDERS (2016)
Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment
Kejal Kantarci et al.
NEUROLOGY (2016)
Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations
Sam T. Creavin et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Amyloid deposition in Parkinson's disease and cognitive impairment: A systematic review
Myria Petrou et al.
MOVEMENT DISORDERS (2015)
Valproic Acid for Treatment of Hyperactive or Mixed Delirium: Rationale and Literature Review
Yelizaveta Sher et al.
PSYCHOSOMATICS (2015)
Melatonin therapy for REM sleep behavior disorder: a critical review of evidence
Ian R. McGrane et al.
SLEEP MEDICINE (2015)
Cognitive Tests to Detect Dementia A Systematic Review and Meta-analysis
Kelvin K. F. Tsoi et al.
JAMA INTERNAL MEDICINE (2015)
Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis
Hui-Fu Wang et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)
Clinical and Cognitive Phenotype of Mild Cognitive Impairment Evolving to Dementia with Lewy Bodies
Annachiara Cagnin et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2015)
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
Alisdair McNeill et al.
BRAIN (2014)
Atrophy of the cholinergic basal forebrain in dementia with Lewy bodies and Alzheimer's disease dementia
Michel J. Grothe et al.
JOURNAL OF NEUROLOGY (2014)
18F-FDG PET and Perfusion SPECT in the Diagnosis of Alzheimer and Lewy Body Dementias
John T. O'Brien et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
TARGETING THE LOW-HANGING FRUIT OF NEURODEGENERATION
Amanda R. Mason et al.
NEUROLOGY (2014)
Dementia with Lewy bodies Basis of cingulate island sign
Jonathan Graff-Radford et al.
NEUROLOGY (2014)
Tailored lighting intervention improves measures of sleep, depression, and agitation in persons with Alzheimer's disease and related dementia living in long-term care facilities
Mariana G. Figueiro et al.
CLINICAL INTERVENTIONS IN AGING (2014)
Incidence of Dementia With Lewy Bodies and Parkinson Disease Dementia
Rodolfo Savica et al.
JAMA NEUROLOGY (2013)
Donepezil for Dementia with Lewy Bodies: A Randomized, Placebo-Controlled Trial
Etsuro Mori et al.
ANNALS OF NEUROLOGY (2012)
Olanzapine-Induced Neuroleptic Malignant Syndrome in a Patient With Probable Dementia With Lewy Bodies
Po-Ren Teng et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2012)
Comparison of cognitive decline between dementia with Lewy bodies and Alzheimer's disease: a cohort study
Zuzana Walker et al.
BMJ OPEN (2012)
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease
Michal Rolinski et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Which medications to avoid in people at risk of delirium: a systematic review
Andrew Clegg et al.
AGE AND AGEING (2011)
Familial Aggregation of Dementia With Lewy Bodies
Angela Nervi et al.
ARCHIVES OF NEUROLOGY (2011)
5-HT6 receptor and cognition
Xabier Codony et al.
CURRENT OPINION IN PHARMACOLOGY (2011)
Altered function of glutamatergic cortico-striatal synapses causes output pathway abnormalities in a chronic model of parkinsonism
Ruth Warre et al.
NEUROBIOLOGY OF DISEASE (2011)
Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies
T. J. Ferman et al.
NEUROLOGY (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
Mild cognitive impairment associated with limbic and neocortical lewy body disease: a clinicopathological study
Jennifer Molano et al.
BRAIN (2010)
Nelotanserin, a Novel Selective Human 5-Hydroxytryptamine(2A) Inverse Agonist for the Treatment of Insomnia
Hussien A. Al-Shamma et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
Murat Emre et al.
LANCET NEUROLOGY (2010)
Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial
Dag Aarsland et al.
LANCET NEUROLOGY (2009)
Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder
R. B. Postuma et al.
NEUROLOGY (2009)
Valproate preparations for agitation in dementia
Edmund Lonergan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
Effects of Dopaminergic Medications on Psychosis and Motor Function in Dementia with Lewy Bodies
Jennifer G. Goldman et al.
MOVEMENT DISORDERS (2008)
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Julie A. Schneider et al.
NEUROLOGY (2007)
Quetiapine for agitation or psychosis in patients with dementia and parkinsonism
Roger Kurlan et al.
NEUROLOGY (2007)
DLB and PDD boundary issues - Diagnosis, treatment, molecular pathology, and biomarkers
C. F. Lippa et al.
NEUROLOGY (2007)
Efficacy and safety of galantamine in patients with dementia with Lewy bodies: A 24-week open-label study
Keith Edwards et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2007)
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease
Lon S. Schneider et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Interface between tauopathies and synucleinopathies: A tale of two proteins
WR Galpern et al.
ANNALS OF NEUROLOGY (2006)
Pharmacotherapy of dementia with Lewy bodies
HH Fernandez et al.
EXPERT OPINION ON PHARMACOTHERAPY (2003)
Tau pathology in the olfactory bulb correlates with Braak stage, Lewy body pathology and apolipoprotein ε4
Y Tsuboi et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2003)
Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients
BF Boeve et al.
SLEEP MEDICINE (2003)
Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies
AR Merdes et al.
NEUROLOGY (2003)
Dementia with Lewy bodies may present as dementia and REM sleep behavior disorder without parkinsonism or hallucinations
TJ Ferman et al.
JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY (2002)
Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD
K Lobotesis et al.
NEUROLOGY (2001)
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study
I McKeith et al.
LANCET (2000)
Quantifying fluctuation in dementia with Lewy bodies, Alzheimer's disease, and vascular dementia
MP Walker et al.
NEUROLOGY (2000)
Share Paper
